Efficacy and safety of adalimumab in paediatric patients with moderate-to-severe ulcerative colitis (ENVISION I): a randomised, controlled, phase 3 study
View/ Open
Volume
6
Pagination
616 - 627
DOI
10.1016/S2468-1253(21)00142-4
Journal
LANCET GASTROENTEROLOGY & HEPATOLOGY
Issue
Metadata
Show full item recordAuthors
Croft, NM; Jr, FWA; Kugathasan, S; Kierkus, J; Ruemmele, FM; Shimizu, T; Mostafa, NM; Venetucci, M; Finney-Hayward, T; Gonzalez, YSCollections
- Centre for Immunobiology [1121]